| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Bosentan | FAERS: 8 | US FAERS | |
| 2 | ambrisentan | FAERS: 8 | US FAERS | |
| 3 | Cinacalcet | FAERS: 5 | US FAERS | |
| 4 | Lenalidomide | FAERS: 5 | US FAERS | |
| 5 | treprostinil | FAERS: 5 | US FAERS | |
| 6 | macitentan | FAERS: 3 | US FAERS | |
| 7 | paricalcitol | FAERS: 3 | US FAERS | |
| 8 | Warfarin | FAERS: 2 | US FAERS | |
| 9 | apixaban | FAERS: 2 | US FAERS | |
| 10 | patiromer | FAERS: 2 | US FAERS | |
| 11 | pomalidomide | FAERS: 2 | US FAERS | |
| 12 | 2-[(E)-[1-(2-Amino-1,3-thiazol-4-yl)-2-[[(2S,3S)-2-methyl-4-oxo-1-sulfoazetidin-3-yl]amino]-2-oxoethylidene]amino]oxy-2-methylpropanoic acid;(2S)-2,6-diaminohexanoic acid | FAERS: 1 | US FAERS | |
| 13 | Axitinib | FAERS: 1 | US FAERS | |
| 14 | Everolimus | FAERS: 1 | US FAERS | |
| 15 | Fingolimod Hydrochloride | FAERS: 1 | US FAERS | |
| 16 | Gabapentin | FAERS: 1 | US FAERS | |
| 17 | Lansoprazole | FAERS: 1 | US FAERS | |
| 18 | Rifaximin | FAERS: 1 | US FAERS | |
| 19 | Risperidone | FAERS: 1 | US FAERS | |
| 20 | Sildenafil Citrate | FAERS: 1 | US FAERS | |
| 21 | Ticagrelor | FAERS: 1 | US FAERS | |
| 22 | Valsartan | FAERS: 1 | US FAERS | |
| 23 | ivacaftor | FAERS: 1 | US FAERS | |
| 24 | teduglutide | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.